Aug 2016 CURRICULUM VITAE

Name Anand P. Chokkalingam

Work Addresses Division of Epidemiology Department of Drug Safety and Public Health Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404 Phone: (650) 372-7213 E-mail: anand.chokkalingam@gilead.com

Division of Epidemiology School of Public Health University of California, Berkeley Berkeley, CA 94720 E-mail: anandc@berkeley.edu

Citizenship USA

Education

1994 B.A. (Molecular and Cellular Biology: Biochemistry; Minor in South Asian Studies), University of California, Berkeley

1997 M.S. (Epidemiology and Preventive Medicine), University of Maryland, Baltimore

2001 Ph.D. (Epidemiology), University of Maryland, Baltimore Thesis: Vitamin D receptor gene polymorphisms, insulin-like growth

factors, and prostate cancer risk: a population-based case-control study in China

2001-2 Postdoctoral Fellowship. (Cancer Epidemiology), Division of Cancer Epidemiology and Genetics, National Cancer Institute

Specialty Training

2000 Molecular Epidemiology Workshop, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD

2001 Pathobiology of Cancer Workshop, American Association for Cancer Research, Keystone, CO

2003 Human Genome Epidemiology (HuGE) Workshop, Centers for Disease Control and Prevention, Atlanta, GA

Chronology of Employment

1992-1993 Student Researcher, Department of Ophthalmology, Stanford University Medical Center, Stanford, CA

1994-1996 Chemist, Behring Diagnostics, Inc., Cupertino, CA

AP Chokkalingam 2

1996-1997 Research Assistant, Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

1997-1999 Graduate Research Assistant, Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

1998-2000 Epidemiology Consultant, Professional Services Consultants, Inc., Bel Air, MD

1999 Epidemiology Consultant, The Weinberg Group, Washington, DC

1999 Epidemiology of Aging Trainee, Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

1999 Special Guest Researcher, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD

2000-2002 Cancer Research Training Award Fellow, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD

2002-2005 Senior Scientist, Celera Diagnostics LLC, Alameda, CA

2005-2012 Assistant Researcher, Division of Epidemiology, School of Public Health, University of California at Berkeley, Berkeley, CA

2007-2012 Assistant Adjunct Professor, Division of Epidemiology, School of Public Health, University of California at Berkeley, Berkeley, CA

2010-2016 Invited Professor, Centre INRS-Institut Armand Frappier, Montreal, Canada

2012-2013 Associate Researcher, Division of Epidemiology, School of Public Health, University of California at Berkeley, Berkeley, CA

2013-2016 Associate Director, Epidemiology, Department of Drug Safety and Public Health, Gilead Sciences Inc., Foster City, CA

2012-pres Associate Adjunct Professor, Division of Epidemiology, School of Public Health, University of California at Berkeley, Berkeley, CA

2016-pres Director, Epidemiology, Department of Drug Safety and Public Health, Gilead Sciences Inc., Foster City, CA

Awards/Honors

1997-1999 Graduate Research Assistantship, Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

1998 First Place – Epidemiology, Twentieth Annual Graduate Student Research Day, University of Maryland at Baltimore, Baltimore, MD

1999 National Research Service Award Pre-Doctoral Fellowship, Epidemiology of Aging, National Institute on Aging

2000-2001 Cancer Research Training Award Pre-Doctoral Fellowship, National Cancer Institute

AP Chokkalingam 3

2001-2002 Cancer Research Training Award Post-Doctoral Fellowship, National Cancer Institute

2001 Selected for American Association for Cancer Research Pathobiology of Cancer Workshop, Keystone, CO

2001 Fellows Award for Research Excellence (FARE) 2002, National Institutes of Health

2001 Research award on prostate cancer: Survey of Prostate Cancer in Accra, Ghana. Office of Research on Minority Health, National Institutes of Health

2002 Outstanding Research Paper by a Fellow Award 2001, Division of Cancer Epidemiology and Genetics, National Cancer Institute

2002 Continuing research award on prostate cancer: Survey of Prostate Cancer in Accra, Ghana. Center to Reduce Health Disparities, National Institutes of Health

2014, 2015 Values at Work Award, Gilead Sciences Inc.

2015 Nominated to attend Director Development Program, Gilead Sciences Inc.

Research Interests

Cancer, hepatitis C, molecular diagnostics, molecular epidemiology, genetic susceptibility, pharmaco-epidemiology, “real world” data

Research Support and Responsibilities

Past/Completed

Grant #25629 (PI: Chokkalingam) 07/2013 * Alex’s Lemonade Stand Foundation “Role of Fetal Growth in Pediatric Rhabdomyosarcoma” This project examines fetal growth characteristics and fetal growth genes in up to 700 pediatric rhabdomyosarcoma cases diagnosed in California. Role: Principal Investigator $199,914 (total) * awarded but declined due to change in full-time position

Grant # R01 ES09137 (PI: Buffler) 09/2009 – 08/2014 National Institute of Environmental Health Sciences / National Cancer Institute “Environmental and Molecular Epidemiology of Childhood Leukemias” A project to continue case and control ascertainment and perform large-scale genetic investigations in an ongoing population-based case-control study of childhood leukemia Role: Co-investigator $11,010,647 (total)

Grant # P01 ES018172 (PI: Buffler) 09/2009 – 07/2014 National Institute of Environmental Health Sciences /Environmental Protection Agency “Center for Integrative Research on Childhood Leukemia and the Environment (CIRCLE)” A program project to assess the role of environmental exposures on the biology and etiology of childhood leukemia.

AP Chokkalingam 4

Role: Co-investigator $7,475,835 (total)

Grant # R01 CA155461 (Co-PIs: J. Wiemels, UCSF and X. Ma, Yale) 07/2011 – 04/2014 National Cancer Institute

The goal of this project is to discover genetic risk factors for childhood acute lymphobastic leukemia, and examine the relationship between these genetic risk and fetal growth variables in leukemia incidence. We will explore the impact of these variables on Hispanics and Whites in California to investigate why Hispanics have a higher rate of leukemia, significantly improving our understanding of the causes of this disease in the most vulnerable populations. Role: Co-Investigator $1,186,157 (Berkeley subcontract)

Grant # PARMA9205 (PI: M-E. Parent, INRS, Canada) 10/2010 - 09/2015

Cancer Research Society (Canada) “Quebec Research Program for Prostate Cancer Prevention” This study based in Montreal, Canada, proposes to (1) perform a genome-wide association study with emphasis on variants that may modify the effects of occupational and environmental exposures on prostate cancer, in existing samples for 3000 subjects (1500 cases and 1500 controls), and (2) perform replication analyses of observed interactions in 1000 newly collected subjects (500 cases and 500 controls). Role: Collaborator $4,728,203 (total)

Award # 2008/081 (PI: Chokkalingam) 5/2009 – 4/2012 Children with Leukaemia Foundation, UK “Mechanistic studies of folate as a risk factor for childhood ALL” This study proposes to examine the combined role of maternal dietary folate with maternal and child’s folate metabolism genes in childhood ALL. Role: Principal Investigator $332,032 (total)

Grant # 27787 (PI: Hsing) 09/2008 – 08/2012

United States Department of Defense, Congressionally Directed Medical Research Program “Circadian Genes and Risk for Prostate Cancer” A project to assess the role of genetic variants in circadian rhythm genes in prostate cancer risk. Role: Co-investigator $329,538 (total)

Grant # R03CA125823 (PI: Buffler) 08/2007 - 07/2011 National Cancer Institute “MHC genetic variation, exposure to infections, and risk of childhood leukemia” A project to investigate the role of individual genetic variation in the MHC in the etiology of childhood acute lymphocytic leukemia. Role: Co-investigator $122,770 (total)

Award # 2006/051 (PI: Chokkalingam) 02/2007 – 01/2010

Children with Leukaemia Foundation, UK “Variation in genes of the MHC, exposure to infections and risk of childhood acute lymphoblastic leukemia”

AP Chokkalingam 5

This study proposes to examine the combined role of the major histocompatibility complex (MHC) genes, including human leukocyte antigen (HLA), and exposure to childhood infections, in etiology of childhood ALL. Role: Principal Investigator

Award # 2006/053 (PI: Selvin) 02/2007-01/2009 Children with Leukaemia Foundation, UK “Admixture and Infectious Exposures in the Etiology of Childhood Leukemia” A project to assess the role of genetic ancestry in modifying the effects of infections on risk of childhood leukemia. Role: Co-investigator

Award # 2005/028 (PI: Buffler) 12/2005-11/2008 Children with Leukaemia Foundation, UK “Individual genetic susceptibility and environmental exposures in the etiology of childhood leukemia” A project to exmine the role of candidate genes and environmental exposures in childhood leukemia risk. Role: Co-investigator

Award # 2005/027 (PI: Block/Buffler) 12/2005-11/2008 Children with Leukaemia Foundation, UK “Effect of maternal and child diet and folate metabolism gene variants on childhood leukemia risk” A project to examine the role of dietary factors including self-reported dietary folate in conjunction with diet-related genes in childhood leukemia risk Role: Co-investigator

Grant # R01 ES09137 (PI: Buffler) 05/2004 – 03/2009 National Institute of Environmental Health Sciences “Childhood Leukemia and Environmental Exposures” A project to ascertain case and control subjects for assessment of environmental exposures as risk factors for childhood leukemia Role: Co-investigator $5,945,937 (total)

Societies and Memberships

2000-date Society for Epidemiologic Research

2001-date American Association for Cancer Research

2005-2013 Childhood Leukemia International Consortium; Genetics Working Group Co-chair (2006-9)

Service

1997-1999 Graduate Program Committee (Student Representative), Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

AP Chokkalingam 6

1997-1998 Strategic Planning Committee, Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

1998-1999 Admissions and Student Affairs Subcommittee (Student Representative), Graduate Program Committee, Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

2001 Mail-in grant reviewer, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health

2008 Grant reviewer, Children with Leukaemia Foundation (United Kingdom)

2009 Grant reviewer, Sparks Charity (United Kingdom)

2010 Regular Member, Cancer Etiology Grant Review Panel, Canadian Cancer Society Research Institute

2011 Regular Member, Interventions to Prevent Cancer Panel, Canadian Cancer Society Research Institute

2012 Grant reviewer, Children with Cancer Foundation (United Kingdom)

2007-pres Graduate Group in Epidemiology, School of Public Health, University of California, Berkeley

Conference Organizing

2011 Co-Chair, Session on Prostate Cancer Epidemiology, International Congress of Epidemiology, Montreal, Canada

2012 Co-Chair, Consensus Statement Development; Childhood Leukaemia Risks: Towards A Better Understanding Of Unexplained Results; MELODI Scientific Workshop, Jointly Organised by BfS and IRSN. Bombon, France

Review for Professional Journals

(bold indicates reviews since appointment at UC Berkeley)

Arthritis and Rheumatism

Blood

Cancer Causes and Control

Cancer Epidemiology, Biomarkers, and Prevention

Cancer Genetics and Cytogenetics

Carcinogenesis

Environmental Health Perspectives

European Journal of Cancer

Expert Review of Molecular Diagnostics

International Journal of Cancer

Lancet Oncology

AP Chokkalingam 7

Nutrition and Cancer

Pediatric Blood and Cancer

Prostate Cancer

Prostate Cancer and Prostatic Diseases

The Prostate

Public Health Genomics

Urology

A. Peer-Reviewed Publications

A1. Sharma-Wagner S, Chokkalingam AP, Malker HSR, Stone BJ, McLaughlin JK, Hsing AW. Occupation and prostate cancer risk in Sweden. J Occ Env Med. 2000; 42:517-525.

A2. Chokkalingam AP, Pollak M, Fillmore C-M, Gao Y-T, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev. 2001; 10:421-427.

A3. Chokkalingam AP, McGlynn KA, Gao Y-T, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China. Cancer Res. 2001; 61:4333-4336.

A4. Hsing AW, Chen C, Chokkalingam AP, Gao Y-T, Dightman DA, Nguyen H, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JKV. Polymorphic SRD5A2 markers and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2001; 10:1077-1082.

A5. Hsing AW, Chokkalingam AP, Gao Y-T, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chang C. Polymorphic CAG/CAA repeat lengths in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2002; 11:337-41.

A6. Chokkalingam AP, Gao Y-T, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW. Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate. 2002; 52:98-105.

A7. Dahle SE, Chokkalingam AP, Gao Y-T, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Hsing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol. 2002;168:599-604.

A8. Hsing AW, Chokkalingam AP, Gao Y-T, Madigan MP, Deng J, Gridley G, Fraumeni JF Jr. Allium vegetables and risk of prostate cancer: a population-based study. J Natl Cancer Inst. 2002; 94:1648-1651.

AP Chokkalingam 8

A9. Chokkalingam AP, Nyren O, Johannson JE, Gridley G, McLaughlin JK, Adami HO, Hsing AW. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden. Cancer. 2003;98:1727-1734.

A10. Loffredo CA, Chokkalingam AP, Sill AM, Boughman JA, Clark AB, Scheel J, Brenner JI. Prevalence of congenital cardiovascular malformations among relatives of infants with hypoplastic left heart, coarctation of the aorta, and d-transposition of the great arteries. Am J Med Genet. 2004; 124A:225-30.

A11. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie K, Huang Q, Smith AM, Spoerke JM, Conn MP, Chang M, Chang S-YP, Saiki RK, Catanese JJ, Leong DU, Garcia VE, Jeffery DA, Lee A, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK. A missense SNP in the protein tyrosine phosphastase PTPN22 is associated with rheumatoid arthritis. Am J Hum Genet. 2004; 75:330-7.

A12. Ritchey JD, Huang W-Y, Gao Y-T, Chokkalingam AP, Deng J, Levine P, Stanczyk FZ, Hsing AW. Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev. 2005; 14:1703-9.

A13. Carlton VEH, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, Chang M, Catanese JJ, Leong DU, Ardlie KG, Kastner DL, Seldin MF, Criswell LA, Gregersen PK, Beasley E, Thomson G, Amos CI, Begovich AB. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet. 2005; 77:567-81.

A14. Wesoly J, van der Helm-van Mil AH, Toes RE, Chokkalingam AP, Carlton VE, Begovich AB, Huizinga TW. Association of the PTPN22 C1858T SNP with RA phenotypes in an inception cohort: the risk allele influences susceptibility but not severity. Arthritis Rheum. 2005; 52(9):2948-50

A15. Ioannidis JPA, Gwinn ML, Little J, Higgins JPT, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter D, Jarvelin M-R, Malmer B, Manolio T, Maraganore DM, Newton-Bishop JA, O’Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ, Human Genome Epidemiology Network, Network of Investigator Networks. A road map for efficient and reliable human genome epidemiology. Nat Genet. 2006; 38:3-5.

A16. Park SK, Sakoda LC, Kang D, Chokkalingam AP, Shin HR, Ahn YO, Shin MH, Lee CW, Lee DH, Blair A, Devesa SS, Hsing AW. Rising prostate cancer rates in South Korea. Prostate. 2006; 66:1285-91.

A17. Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J, Catanese JJ, Leong DU, Ross D, Hu X, Monto A, McAllister LB, Broder S, White T, Sninsky JJ, Wright TL.

AP Chokkalingam 9

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology. 2006; 130:1679-87.

A18. Hsing AW and Chokkalingam AP. Prostate cancer epidemiology. Front Biosci, 2006; 11:1388-413.

A19. Iakoubova OA, Tong CH, Chokkalingam AP, Rowland CM, Kirchgessner TG, Louie JZ, Ploughman LM, Sabatine MS, Campos H, Catanese JJ, Leong DU, Young BA, Lew D, Tsuchihashi Z, Luke MM, Packard CJ, Zerba KE, Shaw PM, Shepherd J, Devlin JJ, Sacks FM. Asp113Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS. Arterioscler Thromb Vasc Biol. 2006; 26:2763-8.

A20. Seminara D, Khoury MJ, O'Brien TR, Gwinn ML, Little J, Higgins JPT, Bernstein JL, Boffetta P, Bondy M, Bray MS, BrenchleyPE, Buffler PA, Casas JP, Chokkalingam AP, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter D, Jarvelin M-R, Malmer B, Manolio T, Maraganore DM, Newton-Bishop JA, Riboli E, Salanti G, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Ioannidis JPA, for the Human Genome Epidemiology Network and the Network of Investigator Networks. The emergence of networks in human genome epidemiology: challenges and opportunities. Am J Epidemiol. 2007; 18:1-8.

A21. Feitsma AL, Toes REM, Begovich AB, Chokkalingam AP, de Vries RRP, Huizinga TWJ, van der Helm-van Mil AHM. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients. Rheumatology. 2007 Mar 6; [Epub ahead of print].

A22. Kang D, Chokkalingam AP, Gridley G, Nyren O, Johansson J-E, Adami H-O, Blair A, Silverman D, Hsing AW. Benign prostatic hyperplasia and risk of bladder cancer: a population-based cohort study in Sweden. Br J Cancer. 2007; 96:1475-9.

A23. Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev, 2007; 16:1172-7.

A24. Chokkalingam AP, Hsing AW, Stanczyk FZ, Reichardt JKV. Molecular epidemiology of hormone metabolizing loci in prostate cancer. Front Biosci, 2007; 12:3436-60.

A25. Hsing AW, Sakoda LC, Chen J, Chokkalingam AP, Sesterhenn I, Gao, Y-T, Xu J, Zheng SL. MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China. Carcinogenesis. 2007; 28:2530-6.

A26. Ioannidis JP, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan S, Flanders WD, Higgins JPT, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury

AP Chokkalingam 10

MJ. Assessment of cumulative cvidence on genetic associations: interim guidelines. Int J Epidemiol. 2008; 37:120-32.

A27. Chu LW, Zhu Y, Yu K, Zheng T, Yu H, Zhang Y, Sesterhenn I, Chokkalingam AP, Danforth KN, Shen MC, Stanczyk FZ, Gao YT, Hsing AW. Variants in circadian genes and prostate cancer risk: a population-based study in China. Prostate Cancer Prostatic Dis. 2007 Nov 6.

A28. Chokkalingam AP and Buffler PA. Genetic susceptibility to childhood leukemia. Radiat Prot Dosimetry. 2008;132(2):119-29.

A29. Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA. NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol. 2008; 168:1221-32.

A30. Chu LW, Zhu Y, Yu K, Zheng T, Chokkalingam AP, Stanczyk FZ, Gao YT, Hsing AW. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Cancer Epidemiol Biomarkers Prev. 2008; 17:3268-73.

A31. Taylor M, Hussain A, Urayama K, Chokkalingam A, Thompson P, Trachtenberg E, Buffler P. The human major histocompatibility complex and childhood leukemia: An etiological hypothesis based on molecular mimicry. Blood Cells Mol Dis. 2009 Mar-Apr;42(2):129-35.

A32. Chang JS, Buffler PA, Metayer C, Chokkalingam AP, Patoka J, Kronish D, Wiemels JL. Maternal immunoglobulin E and childhood leukemia. Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2221-7.

A33. Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JP, Janssens AC, Ostell J, Owen RP, Pagon RA, Rebbeck TR, Rothman N, Bernstein JL, Burton PR, Campbell H, Chockalingam A, Furberg H, Little J, O'Brien TR, Seminara D, Vineis P, Winn DM, Yu W, Ioannidis JP. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol. 2009;170:269-79.

A34. Chang JS, Wiemels JL, Chokkalingam AP, Metayer C, Barcellos LF, Hansen HM, Aldrich MC, Guha N, Urayama KY, Scélo G, Green J, May SL, Kiley VA, Wiencke JK, Buffler PA. Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2010;19:2152-63.

A35. Urayama KY, Ma X, Selvin S, Metayer C, Chokkalingam AP, Wiemels JL, Does M, Chang J, Wong A, Trachtenberg E, Buffler PA. Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer. 2011;128:1632-43

A36. Metayer C, Scelo GA, Chokkalingam AP, Barcellos LF, Aldrich MC, Chang JS, Guha N, Urayama KY, Hansen HM, Block G, Kiley VA, Wiencke JK, Wiemels JL, Buffler PA. Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2011;22:1243-58

AP Chokkalingam 11

A37. Meyer TE, Chu LW, Li Q, Yu K, Rosenberg PS, Menashe I, Chokkalingam AP, Quraishi SM, Huang W-Y, Weiss JM, Kaaks R, Hayes RB, Chanock SJ, Hsing AW. The association between inflammation-related genes and serum androgen levels in men: The Prostate, Lung, Colorectal, and Ovarian Study. Prostate. 2011 Apr 25. doi: 10.1002/pros.21407. [Epub ahead of print]

A38. Chang JS, Zhou M, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2011;20:1736-40

A39. Chokkalingam AP, Yeboah ED, DeMarzo A, Netto G, Yu K, Tettey Y, Adjei A, Jadallah S, Li Y, Chu LW, Chia D, Niwa S, Partin A, Thompson IM, Roehrborn C, Hoover RN, Hsing AW. Prevalence of BPH and lower urinary tract symptoms in West Africans. Prostate Cancer Prostatic Dis. 2011 Sep 13. doi: 10.1038/pcan.2011.43. [Epub ahead of print]

A40. Chokkalingam AP, Bartley K, Wiemels JL, Metayer C, Barcellos LF, Hansen HM, Aldrich MC, Guha N, Urayama KY, Scélo G, Chang JS, Month SR, Wiencke JK, Buffler PA. Haplotypes of DNA repair and cell cycle control genes, x-ray exposure, and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 2011; 22(12):1721-30

A41. Chokkalingam AP, Aldrich M, Bartley K, Hsu L-I, Metayer C, Barcellos LF, Wiemels JL, Wiencke JK, Buffler PA, Selvin S. Matching on race and ethnicity in case-control studies as a means of control for population stratification. Epidemiology Open Access. 2011; 1:101

A42. Chokkalingam AP, Metayer C, Scelo GA, Chang JS, Urayama KY, Aldrich MC, Guha N, Hansen HM, May SL, Dahl GV, Barcellos LF, Wiencke JK, Wiemels JL, Buffler PA. Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 2012; 23(8):1367-75.

A43. Chokkalingam AP, Metayer C, Scelo G, Chang JS, Schiffman J, Urayama KY, Ma X, Hansen HM, Feusner JH, Barcellos LF, Wiencke JK, Wiemels JL, Buffler PA. Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2012 Sep;23(9):1577-85.

A44. Urayama KY, Chokkalingam AP, Metayer C, Ma X, Selvin S, Barcellos LF, Wiemels JL, Wiencke JK, Taylor M, Brennan P, Dahl GV, Moonsamy P, Erlich HA, Trachtenberg E, Buffler PA. HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk. Blood. 2012 Oct 11;120(15):3039-47.

A45. Urayama KY, Chokkalingam AP, Manabe A, Mizutani S. Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia. Int J Hematol. 2013 Jan; 97(1):3-19.

A46. Lee ST, Xiao Y, Muench MO, Xiao J, Fomin ME, Wiencke JK, Zheng S, Dou X, de Smith A, Chokkalingam A, Buffler P, Ma X, Wiemels JL. A global DNA methylation and gene expression analysis of early human B-cell

AP Chokkalingam 12

development reveals a demethylation signature and transcription factor network. Nucleic Acids Res. 2012 Dec 1;40(22):11339-11351.

A47. Chokkalingam AP, Chun D, Noonan EJ, Pfeiffer CM, Zhang M, Taggart DR, Month SR, Wiemels JL, Metayer C, Buffler PA. Blood levels of folate at birth and risk of childhood leukemia. Cancer Epidemiol Biomarkers Prev 2013;22:1088-94

A48. Chokkalingam AP, Hsu L-I, Metayer C, Hansen HM, Barcellos LF, Wiemels JL, Buffler PA. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control 2013;24:1789-95

A49. Walsh K, de Smith AJ, Chokkalingam AP, Metayer C, Dahl GV, Barcellos LF, Wiemels JL, Buffler PA. Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype. Blood 2013;121:4808-9.

A50. Urayama KY, Chokkalingam AP, Manabe A, Mizutani S. Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia. International Journal of Hematology 2013;97:3-19.

A51. Urayama KY, Thompson PD, Taylor M, Trachtenberg EA, Chokkalingam AP. Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence. Frontiers in Oncology 2013;3:300.

A52. Walsh KM, Chokkalingam AP, Hsu LI, Metayer C, de Smith AJ, Jacobs DI, Dahl GV, Loh ML, Smirnov IV, Bartley K, Ma X, Wiencke JK, Barcellos LF, Wiemels JL, Buffler PA. Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children. Leukemia 2013;27:2416-9

A53. Urayama K, Chokkalingam AP, Metayer C, Hansen H, May S, Ramsay P, Wiemels JL, Wiencke JK, Trachtenberg E, Ishida Y, Brennan P, Jolly KW, Termuhlen AM, Taylor M, Barcellos LF, Buffler PA. SNP association mapping across the extended major histocompatibility complex and risk of precursor B-cell acute lymphoblastic leukemia in children. PLOS One 2013;8:e72557

A54. Walsh KM, de Smith AJ, Chokkalingam AP, Metayer C, Roberts W, Barcellos LF, Wiemels JL, Buffler PA. GATA3 risk alleles are associated with ancestral components in Hispanic children with ALL. Blood 2013;122:3385-7.

A55. de Smith AJ, Walsh KM, Ladner MB, Zhang S, Xiao C, Cohen F, Moore TB, Chokkalingam AP, Metayer C, Buffler PA, Trachtenberg EA, Wiemels JL. The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia. Blood 2014;123:2497-503.

A56. Hsing AW, Yeboah E, Biritwum R, Tettey Y, De Marzo AM, Adjei A, Netto GJ, Yu K, Li Y, Chokkalingam AP, Chu LW, Chia D, Partin A, Thompson IM, Quraishi SM, Niwa S, Tarone R, Hoover RN. High prevalence of screen

AP Chokkalingam 13

detected prostate cancer in West Africans: implications for racial disparity of prostate cancer. The Journal of Urology 2014;192:730-5.

A57. Xiao J, Lee ST, Xiao Y, Ma X, Houseman EA, Hsu LI, Roy R, Wrensch M, de Smith AJ, Chokkalingam A, Buffler P, Wiencke JK, Wiemels JL. PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia. International Journal of Cancer Journal International du cancer 2014;135:1101-9.

A58. Thompson P, Urayama K, Zheng J, Yang P, Ford M, Buffler P, Chokkalingam A, Lightfoot T, Taylor M. Differences in meiotic recombination rates in childhood acute lymphoblastic leukemia at an MHC class II hotspot close to disease associated haplotypes. PLOS One 2014;9:e100480.

A59. Walsh KM, de Smith AJ, Welch TC, Smirnov I, Cunningham MJ, Ma X, Chokkalingam AP, Dahl GV, Roberts W, Barcellos LF, Buffler PA, Metayer C, Wiemels JL. Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia. American Journal of Hematology 2014;89:721-5.

A60. Cook MB, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chung CC, Chokkalingam AP, Chu LW, Yeager M, Hutchinson A, Yu K, Rand KA, Haiman CA, African Ancestry Prostate Cancer GC, Hoover RN, Hsing AW, Chanock SJ. A genome-wide association study of prostate cancer in West African men. Human Genetics 2014;133:509-21

A61. Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L, Ibrahim A, Hautman C, Raj PS, Abnet CC, Adjei AA, Ahlbom A, Albanes D, Allen NE, Ambrosone CB, Aldrich M, Amiano P, Amos C, Andersson U, Andriole G, Jr., Andrulis IL, Arici C, Arslan AA, Austin MA, Baris D, Barkauskas DA, Bassig BA, Beane Freeman LE, Berg CD, Berndt SI, Bertazzi PA, Biritwum RB, Black A, Blot W, Boeing H, Boffetta P, Bolton K, Boutron-Ruault MC, Bracci PM, Brennan P, Brinton LA, Brotzman M, Bueno-de-Mesquita HB, Buring JE, Butler MA, Cai Q, Cancel-Tassin G, Canzian F, Cao G, Caporaso NE, Carrato A, Carreon T, Carta A, Chang GC, Chang IS, Chang-Claude J, Che X, Chen CJ, Chen CY, Chen CH, Chen C, Chen KY, Chen YM, Chokkalingam AP, et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Human Molecular Genetics 2014.

A62. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N,

AP Chokkalingam 14

Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Roder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature genetics 2014;46:1103-9

A63. de Smith AJ, Walsh K, Zhang S, Xiao C, Cohen F, Chokkalingam AP, Metayer A, Buffler PA, Trachtenberg E, Wiemels JL. Inhibitory interactions between killer cell immunoglobulin-like receptors and their cognate HLA class I ligands contribute to risk of childhood acute lymphoblastic leukemia. (submitted)

B. Book chapters

B1. Hsing AW and Chokkalingam AP. Epidemiology of prostate cancer. In: Chang C (ed). Prostate cancer : Basic mechanisms and therapeutic approaches. Singapore: World Scientific; 2005.

B2. Chokkalingam AP and Buffler PA. Childhood leukemias. In : Khoury MJ, Bedrosian SR, Gwinn M, Higgins JPT, Ioannidis JPA, Little J (eds). Human genome epidemiology (Second edition): Building the evidence for using genetic information to improve health and prevent disease. Oxford: Oxford University Press; 2010.

C. Abstracts/Presentations

C1. Maurice DM, Chokkalingam A. Interferometric measurement of corneal thickness changes as a result of mechanical stress. Invest Ophthalmol Vis Sci. 1994; 35(4):1358. Presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL; 1994.

C2. Chokkalingam A, Robinson K, Dickersin K. Comprehensive identification of child health-specific controlled trials. Presented at the Nineteenth Annual Graduate Student Research Day, University of Maryland, Baltimore, MD; 1997.

C3. Chokkalingam A, Scherer R, Dickersin K. Agreement of data in abstracts compared to full publications. Presented at the Twentieth Annual Graduate Student Research Day, University of Maryland, Baltimore, MD; 1998.

C4. Chokkalingam A, Scherer R, Dickersin K. Agreement of data in abstracts compared to full publications. Control Clin Trials. 1998; 19(3S):61-62S. Presented at the Nineteenth Annual Meeting of the Society for Clinical Trials, Atlanta, GA; 1998

C5. Chokkalingam A, Scherer R, Dickersin K. Concordance of data between conference abstracts and full reports. Presented at the Sixth International Cochrane Colloquium, Baltimore, MD; 1998

AP Chokkalingam 15

C6. Loffredo CA, Chokkalingam A, Sill A, Boughman JA, Scheel J, Brenner JI. Prevalence of congenital heart disease among 1st, 2nd, and 3rd degree relatives of infants with hypoplastic left heart, coarctation of the aorta, and transposition of the great arteries, in comparison to a control population. Pediatr Res. 2000; 47(4) 898, Pt 2 Suppl. S. Presented at the Annual Meeting of the Pediatric Academic Societies, Boston, MA; 2000.

C7. Hsing AW, Chua S, Gao Y-T, Chokkalingam AP, Stanczyk F. Serum levels of insulin and leptin in relation to prostate cancer risk: a population-based case-control study in China. Presented at the 92nd Annual Meeting of the American Association for Cancer Research, New Orleans, LA; 2001.

C8. Chokkalingam AP, Deng J, Gao Y-T, Pollak M, Stolley PD, McGlynn KA, Hsing AW. Insulin-like growth factors, vitamin D receptor gene polymorphisms, and prostate cancer risk: a population-based case-control study in China. Presented at the 92nd Annual Meeting of the American Association for Cancer Research, New Orleans, LA; 2001.

C9. Hsing AW, Chokkalingam AP. Prostate cancer: rates, risk factors, and genetics. Presented at the NCI Genitourinary Malignancies Faculty Retreat, Bethesda, MD; 2002.

C10. Hsing AW, Gridley G, Deng J, Chokkalingam AP, Madigan P, Sesterhenn I, Mostofi FK, Lee M, GaoY-T. Diet and prostate cancer: a population-based study in China. Presented at the 93nd Annual Meeting of the American Association for Cancer Research, San Francisco, CA; 2002.

C11. Chokkalingam AP, Nyren O, Adami H-O, Gridley G, McLaughlin JK, Fraumeni JF Jr, Hsing AW. The risk of prostate cancer following benign prostatic hyperplasia: a population-based cohort study. Presented at the 93nd Annual Meeting of the American Association for Cancer Research, San Francisco, CA; 2002.

C12. Ritchey JD, Huang W-Y, Gao Y-T, Chokkalingam AP, Deng J, Levine P, Stanczyk FZ, Hsing AW. Genetic variants of DNA repair genes and prostate cancer: a population-based study. Presented at the 95th Annual Meeting of the American Association for Cancer Research, Orlando, FL; 2004.

C13. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SP, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK. A missense SNP in the protein tyrosine phosphatase PTPN22 is associated with rheumatoid arthritis. Presented at the European Rheumatology Meeting (EULAR), Berlin, Germany; 2004.

C14. Iakoubova OA, Sacks FM, Chokkalingam AP, Sabatine MS, Ray KK, Campos H, Kirchgessner TG, Ranade K, Tong CH, Tsuchihashi Z, Packard CJ, Ploughman LM, Zerba KE, Shepherd J, Shaw PM, Devlin JJ, Dracopoli NC. Association of polymorphisms in the IgA Fc receptor and ABCA1 genes with myocardial infarction and other coronary events in the CARE

AP Chokkalingam 16

and WOSCOPS trials. Presented at the American Heart Association Scientific Sessions, New Orleans, LA; 2004.

C15. Kirchgessner TG, Ploughman LM, Zerba KE, Ranade K, Devlin JJ, Iakoubova OA, Sacks FM, Campos H, Ray K, Chokkalingam AP, Tsuchihashi Z, Sninsky JJ, Pfeffer MA, Sabatine MS, Shaw PM, Shepard J, Packard CJ, Braunwald E, Dracopoli NC. Paraoxonase 1 (PON1)192R variant influences statin reduction of coronary heart disease. Presented at the American Heart Association Scientific Sessions, New Orleans, LA; 2004.

C16. Huang H, Shiffman ML, Tuason O, Yee L, Schrodi SJ, Chokkalingam AP, Chan J, Catanese JJ, Leong DU, Emerson R, Monto A, McAllister LB, Layden TJ, Cheung RC, Sninsky JJ, Wright TL. Identification of novel genetic markers associated with fibrosis progression risk in HCV patients from a genomic scan of putative functional polymorphisms. Presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA; 2004.

C17. Carlton V, Schrodi SJ, Hu X, Garcia VE, Alexander H, Chokkalingam AP, Huang Q, Brandon R, Chang M, Ardlie K, Catanese JJ, Leong DU, Criswell LA, Seldin M, Kastner D, Gregersen P, Beasley E, Sninsky JJ, Amos CI, Begovich AB. Protein tyrosine phosphatase PTPN22 and rheumatoid arthritis. Presented at the 68th Annual Scientific Meeting of the American College of Rheumatology, San Antonio, TX; 2004.

C18. Huang H, Wright TL, Cheung RC, Layden TJ, Tuason O, Yee L, Chokkalingam AP, Schrodi SJ, Chan J, Catanese JJ, Leong DU, Emerson R, Monto A, McAllister LB, Sninsky JJ, Shiffman ML. Association of fibrosis risk in HCV patients with a missense SNP in gene CPT1A. Presented at the 40th Annual Meeting of the European Association for the Study of Liver Diseases, Paris, France; 2005.

C19. Huang H, Merriman RB, Chokkalingam AP, Tuason O, Schrodi SJ, Aouizerat BE, Chan J, Catanese JJ, Leong DU, McAllister LB, Sninsky JJ, Bass NM. Novel genetic markers associated with risk of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver diseases. Presented at the Digestive Disease Week 2005, Chicago IL; 2005.

C20. Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. Single nucleotide polymorphisms and haplotypes of the MDR1 gene and risk of childhood leukemia. Presented at the 97th Annual Meeting of the American Association for Cancer Research, Washington, DC; 2006.

C21. Buffler PA, Wiemels JL, Metayer C, Chokkalingam A, Reynolds P, Wiencke JK, Block G, Selvin S, Ma X, Does M, Zhang L, Smith MT. Environmental exposure and the molecular epidemiology of childhood leukemia in California. Presented at the 3rd Annual Asian Pacifc Organization for Cancer Prevention, Bangkok, Thailand.

C22. Urayama KY, Wiemels JL, Chokkalingam AP, Wiencke JK, Barcellos L, Metayer C, Buffler PA. Membrane transporter gene polymorphisms and haplotypes and the risk of childhood acute lymphocytic leukemia.

AP Chokkalingam 17

Presented at the IARC/EACR/AACR/ECNIS Symposium on Integrative Molecular Cancer Epidemiology. Lyon, France, 2008.

C23. Scelo G, Chokkalingam AP, Metayer C, Guha N, Barcellos LF, Wiemels JL, Wiencke JK, Buffler PA. Genetic polymorphisms in cytochrome p450 gene family and risk of childhood acute lymphocytic leukemia. Presented at the IARC/EACR/AACR/ECNIS Symposium on Integrative Molecular Cancer Epidemiology. Lyon, France, 2008.

C24. Chokkalingam AP, Barcellos LF, Block G, Jensen C, Ma X, Metayer C, Wiemels J, Buffler PA. Insulin-like growth factor genes and risk of childhood leukemia. Presented at the AACR Special Conference on Candidate pathways, Whole Genome Scans: Reconciling Results, Looking into the Future. Carefree, AZ, 2008.

C25. Urayama KY, Chokkalingam AP, Metayer C, Wiemels JL, Wiencke J, Trachtenberg E, Taylor M, Brennan P, Hansen H, May S, Barcellos L, Buffler PA. Association Mapping Across the Major Histocompatibility Complex Region in the Risk of Childhood Acute Lymphoblastic Leukemia. Presented at the American Society for Human Genetics Annual Meeting, 2010.

C26. Hsu L-I, Chokkalingam AP, Hansen H, Metayer C, Wiemels JL, Buffler PA. Variants within ARID5B confer risk for childhood ALL in both Hispanic and non-Hispanic White populations. Presented at the annual meeting of the American Society of Human Genetics. 2012.

C27. Noonan EJ, Chokkalingam AP, Metayer C, Wiemels JL, Buffler PA. Newborn folate levels and child’s early diet in risk for childhood acute lymphoblastic leukemia. Presented at the Childhood Cancer 2012 meeting hosted by Children with Cancer UK; London, UK.

C28. Hsu L-I, Chokkalingam AP, Hansen H, Metayer C, Wiemels JL, Buffler PA. Replication of the susceptibility loci on 7p12.2, 10q21.2 and 14q11.2 in acute lymphoblastic leukemia in the California Childhood Leukemia Study (CCLS). Presented at the Childhood Cancer 2012 meeting hosted by Children with Cancer UK; London, UK.

C29. Chokkalingam AP, Chun DS, Hsu L-I, Metayer C, Rabinowitz DJ, Zhang M, Pfeiffer C, Wiemels JL, Buffler PA. Folate levels at birth and risk of acute lymphoblastic leukemia (ALL). Presented at the Childhood Cancer 2012 meeting hosted by Children with Cancer UK; London, UK.

C30. Metayer C, Scelo G, Chokkalingam AP, Barcellos LF, Aldrich MC, Chang JS, Guha N, Urayama KY, Hansen HM, Block G, Kiley V, Wiencke JK, Wiemels JL, Buffler PA. Genetic Variants in the Folate Pathway and Risk of Childhood Acute Lymphocytic Leukemia. Presented at the Childhood Cancer 2012 meeting hosted by Children with Cancer UK; London, UK.

C31.

AP Chokkalingam 18

D. Invited Presentations

D1. Epidemiology Seminar Series. Department of Epidemiology and Preventive Medicine, University of Maryland, Baltimore. Geographic variation in mammography results. 1997

D2. Prostate Cancer Working Group. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. VDR polymorphisms, plasma IGFs, and prostate cancer. 1999.

D3. Epidemiology Seminar Series. Department of Health Research and Policy, Stanford University. IGFs and vitamin D receptor polymorphisms in prostate cancer. 2003.

D4. Epidemiology Seminar Series. Department of Health Research and Policy, Stanford University. DNA repair polymorphisms and risk of prostate cancer. 2005.

D5. Genetic Epidemiology Seminar, Division of Epidemiology, School of Public Health, University of California, Berkeley. Genetic epidemiology in industry. 2005.

D6. Leukemia and Lymphoma Society Field Trip, Northern California Childhood Leukemia Study, School of Public Health, University of California, Berkeley. Studies of genetic susceptibility to childhood leukemia. 2005.

D7. PH250B: Epidemiology Research Seminar, Division of Epidemiology, School of Public Health, University of California, Berkeley. Genetic epidemiology in the Northern California Childhood Leukemia Study. 2006.

D8. HuGENet Workshop on Assessment of Cumulative Evidence on Genetic Associations, Venice, Italy. Childhood leukemia network knowledge base and field synopsis. 2006.

D9. International Symposium on Cancer Research: Integrating Basic, Clinical, and Cancer Research; AC Camargo Cancer Hospital, Sao Paulo, Brazil. Westernization and prostate cancer. 2006.

D10. Genetic and Molecular Epidemiology of Cancer, AC Camargo Cancer Hospital, Sao Paulo, Brazil. Family-based versus population-based genetic association studies. 2006.

D11. PH292: Statistics and Genomics Seminar, Division of Biostatistics, School of Public Health, University of California, Berkeley. Genetic Epidemiology Initiatives in the Northern California Childhood Leukemia Study. 2007.

D12. Parent Support Group Meeting, Kaiser Permanente Medical Center, Santa Clara. Epidemiologic Study to Examine Causes of Childhood Leukemia: The Northern California Childhood Leukemia Study. 2007.

D13. Workshop on Risk Factors for Childhood Leukemia; International Commission on Non-Ionizing Radiation Protection, World Health Organization, Berlin, Germany. Genetic Susceptibility to Childhood Leukemia. 2008.

AP Chokkalingam 19

D14. Parent Support Group Meeting, Kaiser Permanente Medical Center, Santa Clara. The Northern California Childhood Leukemia Study. 2008.

D15. DCEG Fellows Retreat, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville. A Limited Tour Of Epidemiology Outside DCEG. 2009.

D16. Genetic Epidemiology and Toxicology Association, Oakland. Genetic Susceptibility to Childhood Leukemia. 2009.

D17. Cancer Control and Population Sciences Visiting Scholar Series, University of Utah, Salt Lake City. The Northern California Childhood Leukemia Study. 2009.

D18. PH250B: Epidemiology Research Seminar, Division of Epidemiology, School of Public Health, University of California, Berkeley. Epidemiologic Study of Childhood Leukemia. 2009.

D19. Meeting on Childhood Leukemia, Hemato-Oncology Research Unit, Institute for Cancer Research, Surrey, UK. Replication of top ALL GWAS hits in the CCLS. 2012.

D20. Childhood Cancer 2012, Children with Cancer UK Foundation; London, UK. Folate and Childhood ALL. 2012.

D21. Childhood Leukaemia Risks: Towards A Better Understanding Of Unexplained Results; MELODI Scientific Workshop, Jointly Organised by BfS and IRSN, Bombon, France. DNA Repair and Cell Cycle Genes in Childhood Leukemia. 2012.

D22. Genomics Workshop, Cancer Prevention Institute of California; Fremont, CA. SNP Selection in Genetic Epidemiology Studies. 2012.

D23. Genomics Workshop, Cancer Prevention Institute of California; Fremont, CA. Epigenetics in Cancer. 2012.

Teaching

Courses

1993 Teaching Assistant (Introductory Tamil), Department of South and Southeast Asian Studies, University of California, Berkeley, CA

1997 Discussion Facilitator (Epidemiology Workshop), Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

1999 Teaching Assistant (Statistical Computing Laboratory), Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, Baltimore, MD

AP Chokkalingam 20

Fall 2005 Co-instructor (PH298: Genetic Epidemiology Journal Club), Division of Epidemiology, School of Public Health, University of California, Berkeley, CA

Fall 2005 Co-instructor (PH299: Independent Study in Genetic Data Analysis), Division of Epidemiology, School of Public Health, University of California, Berkeley, CA

Spring 2006, 2007, & 2010

Co-instructor (PH258: Cancer Epidemiology), Division of Epidemiology, School of Public Health, University of California, Berkeley, CA

Spring 2013 Instructor (PH293.9: Epidemiology Doctoral Seminar), Division of Epidemiology, School of Public Health, University of California, Berkeley, CA

Student Advising and Mentorship

Master’s students:

Sara E. Dahle, George Washington University (2000, co-advisor with Ann Hsing)

Izzat Sbeih, George Washington University (2001, co-advisor with Ann Hsing)

Alice Kang, UC Berkeley (2008-2010, co-advisor with Patricia Buffler)

Helen Reed, UC Berkeley (2009-2011, co-advisor with Patricia Buffler)

Evan Busch, UC Berkeley (2010, co-advisor with Patricia Buffler)

Emily Noonan Place, UC Berkeley (2011-2012)

Julia Selezneva, UC Berkeley-UCSF Joint Medical Program (2012-2013)

Laura Telep, UC Berkeley (2014-2015)

Doctoral students:

Kevin Y. Urayama, UC Berkeley (2005-2009, co-advisor with Patricia Buffler)

Melinda Aldrich, UC Berkeley (2005-2008, co-advisor with Patricia Buffler)

Neela Guha, UC Berkeley (2005-2008, co-advisor with Patricia Buffler)

Karen Bartley, UC Berkeley (2006-2012, co-advisor with Patricia Buffler)

Ling-I Hsu, UC Berkeley (2009-2013, co-advisor with Patricia Buffler)

Kunchok Dorjee, UC Berkeley (2014-2016)

Post-doctoral students:

Jeffrey S. Chang, UC Berkeley (2007-2009, co-advisor with Patricia Buffler)

Ghislaine A. Scelo, UC Berkeley (2007-2008, co-advisor with Patricia Buffler)

Paul D. Wesson, Gilead Sciences (2016)

AP Chokkalingam 21

Student Committee Participation

2009-11, 2013 Two-year Masters Examination Committee, Division of Epidemiology, UC Berkeley School of Public Health, Berkeley, CA

2009: Jamal Harris, Pierre Noailles, Samantha Pitts, Asieh Zarghani

2010: Ashley Stegall, Katherine Hung, Yun (Tara) Zhang

2011: Melissa Ongpin, Mathilda Regan, Lisa Wong

2013: Jeanna Wallenta, Christine Mineart

2011-13 One-year MPH Seminar Final Presentations, Division of Epidemiology, UC Berkeley School of Public Health, Berkeley, CA

2011: Jason Hong, Tanya Lagrimas

2012: Robyn Lamar, Scott Hyman

2013: Richard Ssekitoleko, Gitome Serah Wagikondi

2010 Doctoral Qualify Examination: Sudeb Dalai, Division of Epidemiology, UC Berkeley School of Public Health, Berkeley, CA

2010-11 Masters Committee: Elana Shpall, Joint Medical Program, UC Berkeley School of Public Health, Berkeley, CA